| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.6M | — | +224.3% |
| SG&A Expense | $7.3M | — | +562.1% |
| Operating Income | -$11.9M | — | -981.6% |
| Pre-tax Income | -$10.5M | — | -67.4% |
| Income Tax | $37K | — | — |
| Net Income | -$10.5M | — | -1622.2% |
| EPS (Basic) | -$0.10 | — | +0.0% |
| EPS (Diluted) | -$0.10 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $76.9M | -20.8% | — |
| Short-term Investments | $198.0M | -1.3% | — |
| Current Assets | $276.7M | -7.6% | — |
| Total Assets | $295.2M | -2.6% | +23.8% |
| Current Liabilities | $5.0M | -14.7% | +260.1% |
| Total Liabilities | $6.6M | -13.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.1M | — | -5924.7% |
| Capital Expenditures | $53K | — | -67.5% |
| Investing Cash Flow | -$11.5M | — | -6153.3% |
| Financing Cash Flow | $149K | — | -98.6% |
| Free Cash Flow | -$9.1M | — | -2813.4% |
| -48.6% |
| Stockholders' Equity | $288.6M | -2.3% | +2489.3% |